Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

Healthcare Biotechnology
"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > radical cystectomy
View:
Post by conspiTheory on Apr 08, 2016 12:33pm

radical cystectomy

The American Society of Clinical Oncology (ASCO) endorsed the European Association of Urology's guideline on muscle-invasive bladder cancer (MIBC) and metastatic bladder cancer and has added qualifying statements, according to a statement published in the Journal of Clinical Oncology.1

“The standard treatment of MIBC is neoadjuvant cisplatin-based combination chemotherapy followed by radical cystectomy,” the authors concluded.

https://www.cancertherapyadvisor.com/urologic-cancers/bladder-cancer-asco-eau-guideline-endorsement/article/487904/

All is well...
Comment by shoestock on Apr 08, 2016 12:48pm
How will this news impact Telesta??...is it a good news?
Comment by LittleLadyPhD on Apr 08, 2016 1:23pm
MCNA has published results and applied for FDA approval for papillary and non-muscle invasive BC, not MIBC or metastatic disease so these results don't affect TST as the applications currently stand.
TELESTA THERAPEUTICS INC
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities